ARTV

Artiva Biotherapeutics (ARTV)

About Artiva Biotherapeutics (ARTV)

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Details

Daily high
$6.30
Daily low
$4.36
Price at open
$6.17
52 Week High
$11.55
52 Week Low
$1.47
Market cap
154.6M
Dividend yield
0.00%
Volume
3.3M
Avg. volume
2.6M
P/E ratio
-1.94

Artiva Biotherapeutics News

Details

Daily high
$6.30
Daily low
$4.36
Price at open
$6.17
52 Week High
$11.55
52 Week Low
$1.47
Market cap
154.6M
Dividend yield
0.00%
Volume
3.3M
Avg. volume
2.6M
P/E ratio
-1.94